findmyKOL
Clinical trialNCT00001120CompletedObservational

A Study of Patients With AIDS Syndrome

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment5,000HIV InfectionsLymphoma, AIDS-RelatedLymphoma, Non-HodgkinSarcoma, Kaposi
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to find out why cancers develop in HIV-positive patients. Cancer is a leading cause of death in AIDS patients. Common cancers in HIV-infected patients include Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), a cancer of the immune system. Risk factors include certain chemicals, viruses, and perhaps even anti-HIV drugs. Doctors would like to find out which risk factors are most important and how they relate to cancer in AIDS patients.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Willow Clinic

    Menlo Park, California, United States

  • San Francisco Gen Hosp

    San Francisco, California, United States

  • Marin County Specialty Clinic

    San Rafael, California, United States

  • San Mateo Aids Program / Stanford Univ

    Stanford, California, United States

  • Stanford Univ Med Ctr

    Stanford, California, United States

  • Univ of Hawaii

    Honolulu, Hawaii, United States

  • Indiana Univ Hosp

    Indianapolis, Indiana, United States

  • Charity Hosp / Tulane Univ Med School

    New Orleans, Louisiana, United States

  • Tulane Univ School of Medicine

    New Orleans, Louisiana, United States

  • Johns Hopkins Hosp

    Baltimore, Maryland, United States

  • Harvard (massachusetts Gen Hosp)

    Boston, Massachusetts, United States

  • Suny / Erie County Med Ctr at Buffalo

    Buffalo, New York, United States

  • Bellevue Hosp / New York Univ Med Ctr

    New York, New York, United States

  • Mem Sloan - Kettering Cancer Ctr

    New York, New York, United States

  • St Mary'S Hosp (univ of Rochester/infectious Diseases)

    Rochester, New York, United States

  • Univ of Rochester Medical Center

    Rochester, New York, United States

  • Univ of North Carolina

    Chapel Hill, North Carolina, United States

  • Duke Univ Med Ctr

    Durham, North Carolina, United States

  • Univ of Cincinnati

    Cincinnati, Ohio, United States

  • Case Western Reserve Univ

    Cleveland, Ohio, United States

  • Metrohealth Med Ctr

    Cleveland, Ohio, United States

  • Ohio State Univ Hosp Clinic

    Columbus, Ohio, United States

  • Univ of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
—
Last update posted
12 Sept 2008
Registered enrollment
5,000
Registry id
NCT00001120

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.